AQR Arbitrage’s Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock ARCK Stock Holding History

AQR Arbitrage’s Portfolio ARCK Stock Details ARCK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-428,345	Closed	-$4.33M	–	1295
2022 Q3	$4.33M	Buy	428,345 +80,800	+23%	+$816K	0.1%	294
2022 Q2	$3.49M	Hold	347,545	–	–	0.08%	331
2022 Q1	$3.48M	Buy	+347,545	New	+$3.48M	0.09%	260

Other funds holding ARCK

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AQR Arbitrage's ARCK Position: Q4 2022 in Review

AQR Arbitrage sold out of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) in Q4 2022, closing a stake of 428,345 shares — an estimated $4.33M sold.

AQR Arbitrage first reported a position in ARCK in Q1 2022 and held it in 3 quarters. The position peaked at $4.33M in Q3 2022. 2 funds tracked by Wall St. Rank hold ARCK as of Q4 2022.

AQR Arbitrage reported no remaining Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position as of Q4 2022 after selling out during the quarter.
AQR Arbitrage sold 428,345 Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock shares in Q4 2022, an estimated $4.33M.
AQR Arbitrage first reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in Q1 2022 and held it in 3 quarters.
AQR Arbitrage's Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position peaked at $4.33M in Q3 2022.
2 funds tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock as of Q4 2022.

Based on AQR Arbitrage's 13F filing for Q4 2022, filed 14 Feb 2023.